Shares of Oragenics, Inc. (NYSEAMERICAN:OGEN – Get Rating) crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.00 and traded as high as $3.58. Oragenics shares last traded at $3.37, with a volume of 7,412 shares.
Oragenics Price Performance
The firm has a market capitalization of $6.60 million, a P/E ratio of -25.92 and a beta of 0.19.
Get Oragenics alerts:Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the business. Renaissance Technologies LLC grew its holdings in shares of Oragenics by 116.5% during the 2nd quarter. Renaissance Technologies LLC now owns 209,600 shares of the biotechnology company's stock worth $73,000 after acquiring an additional 112,800 shares during the period. Millennium Management LLC grew its holdings in shares of Oragenics by 591.6% during the 2nd quarter. Millennium Management LLC now owns 128,733 shares of the biotechnology company's stock worth $45,000 after acquiring an additional 110,119 shares during the period. Finally, State Street Corp grew its holdings in shares of Oragenics by 8.1% during the 1st quarter. State Street Corp now owns 495,563 shares of the biotechnology company's stock worth $171,000 after acquiring an additional 37,338 shares during the period. Hedge funds and other institutional investors own 9.31% of the company's stock.
Oragenics Company Profile
(Get Rating)
Oragenics, Inc develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus.
Read More
- Get a free copy of the StockNews.com research report on Oragenics (OGEN)
- Weight Watchers Reshapes Itself with a Game-Changer Acquisition
- Two Tiny Mining Stocks Worth Considering for the Next Gold Rush
- Nano Dimension Prints Growth: Enters Hypergrowth Phase
- CF Is Set To Harvest The Bull Run In Agricultural Stocks
- Oracle Dips But The Trend Is Strong
Receive News & Ratings for Oragenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oragenics and related companies with MarketBeat.com's FREE daily email newsletter.